Lv52
968 积分 2022-11-28 加入
Biosimilars approved for hematology use: lessons from comparative efficacy studies and comparative analytical assessments
2小时前
待确认
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
2个月前
已完结
Novel drug targets in 2025
3个月前
已完结
Novel drug targets in 2025
3个月前
已关闭
Hepatitis B: A Review
4个月前
已完结
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for Harmonization
7个月前
已完结
Engineering Escherichia coli to biosynthesize O-polysaccharide-derived recombinant Glycoconjugate vaccines against pathogenic serotypes O8 and O9a
8个月前
已完结
Establishment of Limit of In Vitro Cell Age (LIVCA) for Biologics Manufacturing Process
10个月前
已完结
皖公网安备34019202002308
